Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Melanoma Management is Scopus-indexed (Q3, CiteScore 1.2), WoS ESCI, DOAJ. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 2045-0885Verify ISSN ↗2045-0893Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Dermatology | 104 / 152 | 31st | Q3 |
| Oncology | 324 / 428 | 24th | Q4 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2018–present (also 2014–2016), best quartile Q3, CiteScore 1.2.
Melanoma Management is Q3 in Dermatology (rank 104 of 152) and Q4 in Oncology (rank 324 of 428), by CiteScore 2025.
Melanoma Management is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.2, which places it in quartile Q3 at the 31st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.398, quartile Q3, with an H-index of 16.
The publisher lists an article processing charge of about US$1,415 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Melanoma Management is published by Taylor and Francis Ltd. Its print ISSN is 2045-0885 and its online ISSN is 2045-0893.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Melanoma Management has an h-index of 25 and a 2-year mean of 1.64 citations per paper (OpenAlex). Its Scopus CiteScore is 1.2, quartile Q3. On 2-year citations it ranks #47 of 144 Scopus journals in Dermatology.
Melanoma Management published 14 papers in 2025; its busiest recent year was 2017 with 29. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 36 research articles (2021–2026), authors are most often from United States (46.5%), Canada (8.3%) and Türkiye (5.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.